Pandemic Sciences News Today

The Academy of Medical Sciences has elected eight University of Oxford biomedical and health scientists to its fellowship in 2024.

The University of Oxfords Department of Paediatrics has partnered with three Brazilian universities to offer a Translational Science course.

The University of Oxford has begun the first human clinical trials of the ChAdOx1 NipahB vaccine, designed to combat the dangerous Nipah virus. Developed by

The University of Oxford has launched a new clinical trial to test a vaccine to protect people against deadly Nipah virus.

Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.

A new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS) launched last week (Friday 15 September 2023).This is the third Phase I clinical trial of the ChAdOx1 MERS vaccine, developed by researchers at t

The World Health Organization (WHO) recognises MERS as a priority infectious disease that requires urgent research to develop vaccines.

Convalescent plasma -- a once-celebrated treatment for Covid-19 that has largely fallen out of favor -- does work well for people who are immune-compromised, according to a study published Thursday.

Argentine health authorities are investigating a cluster of pneumonia cases from an unknown cause that has led to three deaths out of nine cases ident...

LONDON— The British scientists behind one of the major therapeutic COVID-19 trials have turned their focus to treatments for monkeypox, a viral disease